stemchymal
Cell therapyexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2015 (NCT02540655)
Timeline
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- stemchymal
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06397274 | Phase 2 | Jun 1, 2025 | Steminent Biotherapeutics Inc. |
| NCT03629015 | Phase 1 | Oct 1, 2018 | Steminent Biotherapeutics Inc., Taipei Veteran General hospital |
| NCT02540655 | Phase 2 | Sep 1, 2015 | Steminent Biotherapeutics Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Steminent Biotherapeutics Inc. | For profit | 3 | 3 | 2 | 2015 |
| Taipei Veteran General hospital | Government | 1 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1